APA (7th ed.) Citation

X, H., L, S., Y, F., Z, W., L, W., R, L., . . . Z, J. (2026). Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08633-0

Chicago Style (17th ed.) Citation

X, Han, et al. "Targeted Inhibition of the CREB1-CtIP Axis Enhances the Efficacy of Abiraterone Combined with Radiotherapy in Prostate Cancer." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08633-0.

MLA (9th ed.) Citation

X, Han, et al. "Targeted Inhibition of the CREB1-CtIP Axis Enhances the Efficacy of Abiraterone Combined with Radiotherapy in Prostate Cancer." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08633-0.